Sal Saraceno

With over 20 years of experience advising life sciences companies across all stages of development—from early formation through IPO and post-public growth—I bring a deep understanding of strategic financing and investor engagement within the biotechnology and broader life sciences sector. 

Most recently, I served as Managing Director and Head of Biotechnology Investment Banking at Capital One Securities, where I led the global biotechnology investment banking and equity capital markets initiatives. I was responsible for originating and executing strategic and capital markets transactions, and for managing relationships with biotechnology clients across the sector. 

I previously served as a Director and senior calling officer at BTIG, where I focused on advising biotech companies and institutional investors, identifying and structuring equity financing solutions tailored to the sector’s unique needs. 

I am currently consulting for a private West Coast based oncology Co on strategic matters. 

Most recently, I served as Managing Director and Head of Biotechnology Investment Banking at Capital One Securities, where I led the global biotechnology investment banking and equity capital markets initiatives. I was responsible for originating and executing strategic and capital markets transactions, and for managing relationships with biotechnology clients across the sector. 

 Mandated to drive the global biotechnology investment banking and equity capital markets initiatives at Capital One 

 Oversee sector-wide coverage of biotechnology banking clients and prospects, driving relationship management and business development 

 Served as the senior calling officer for all prospective biotechnology client pitches, leading high-level engagement and deal origination

 Promote and expand adoption of the firm’s product suite, including treasury management, card services, and deposit solutions - among prospective clients 

 Represent Capital One on industry related panels

I previously served as a Director and senior calling officer at BTIG, where I focused on advising biotech companies and institutional investors, identifying and structuring equity financing solutions tailored to the sector’s unique needs.

 Senior calling officer responsible for sourcing and facilitating new business opportunities 

 Responsible for managing relationships with biotech companies covered by equity research, as well as originating and executing private and public financings

  Cultivated strategic relationships with public and private buy-side accounts, leveraging BTIG's sales, trading, and research capabilities to drive issuer engagement

 Mentored junior bankers ensuring deliverables while fostering their professional growth.

Bachelor of Arts, Economics